OrthoPediatrics (NASDAQ:KIDS) Sees Unusually-High Trading Volume – Here’s What Happened

OrthoPediatrics Corp. (NASDAQ:KIDS) saw an uptick in trading volume on Friday . 379,983 shares traded hands during trading, an increase of 122% from the previous session’s volume of 171,488 shares.The stock last traded at $23.61 and had previously closed at $23.32.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on KIDS. Weiss Ratings raised shares of OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. BTIG Research increased their price objective on shares of OrthoPediatrics from $24.00 to $29.00 and gave the company a “buy” rating in a report on Thursday, August 20th. Needham & Company LLC raised their target price on shares of OrthoPediatrics from $30.00 to $35.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. TD Cowen restated a “buy” rating on shares of OrthoPediatrics in a report on Monday, June 15th. Finally, Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 price target (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $26.44.

OrthoPediatrics Trading Up 2.1%

The stock has a market cap of $621.68 million, a price-to-earnings ratio of -14.17 and a beta of 0.98. The business’s 50 day moving average is $21.32 and its 200 day moving average is $18.62. The company has a debt-to-equity ratio of 0.28, a current ratio of 4.78 and a quick ratio of 2.17.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Tuesday, August 4th. The company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The business had revenue of $70.51 million for the quarter, compared to the consensus estimate of $68.21 million. As a group, equities analysts expect that OrthoPediatrics Corp. will post -1.14 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director David R. Pelizzon sold 18,000 shares of the stock in a transaction on Wednesday, August 26th. The shares were sold at an average price of $24.28, for a total value of $437,040.00. Following the transaction, the director directly owned 6,863,464 shares of the company’s stock, valued at $166,644,905.92. This trade represents a 0.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, major shareholder Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock in a transaction on Wednesday, August 26th. The stock was sold at an average price of $24.28, for a total transaction of $437,040.00. Following the sale, the insider owned 6,863,464 shares in the company, valued at $166,644,905.92. This represents a 0.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 114,900 shares of company stock valued at $2,829,906. 32.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On OrthoPediatrics

Several large investors have recently bought and sold shares of the stock. AIGH Capital Management LLC purchased a new stake in shares of OrthoPediatrics in the 2nd quarter valued at about $5,161,000. Wasatch Advisors LP grew its stake in OrthoPediatrics by 56.6% during the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after buying an additional 186,357 shares during the last quarter. Roubaix Capital LLC increased its position in OrthoPediatrics by 23.8% during the first quarter. Roubaix Capital LLC now owns 290,047 shares of the company’s stock worth $4,603,000 after buying an additional 55,724 shares during the period. Granahan Investment Management LLC increased its position in OrthoPediatrics by 35.1% during the first quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock worth $14,231,000 after buying an additional 232,760 shares during the period. Finally, AWM Investment Company Inc. purchased a new stake in OrthoPediatrics in the second quarter valued at approximately $4,537,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.